Affiliation:
1. Consultant Paediatrician & Paediatric Pulmonologist, Mumbai, 400077, India
Abstract
Leishmaniasis, a neglected tropical disease, is caused by protozoal parasites of the genus Leishmania. Clinical manifestations vary from asymptomatic to lethal grade depending on the type of the disease. The currently available antileishmanial drugs suffer from considerable limitations. There is a dire need for better and safer drugs and/or vaccines to eradicate this disease. There are enormous developments ongoing in this field. Newer combinations of existing drugs and newer drugs targeting these intracellular parasites as well as their vectors are being tried to control the disease. Attempts to develop vaccines to enhance the immunity of the patient have shown some promise. This article is a peep into the recent patent developments in this field.
Reference81 articles.
1. Current Visceral Leishmaniasis Research: A Research Review to Inspire Future Study
2. CDC. Parasites-Leishmaniasis. http://www.cdc.gov/parasites/leishmaniasis/index.html Accessed 15 May 2023.
3. WHO. Leishmaniasis. http://www.who.int/data/gho/data/themes/topics/gho-ntd-leishmaniasis Accessed 31 May 2023.
4. WHO. Leishmaniasis. https://www.who.int/news-room/fact-sheets/detail/leishmaniasis Accessed 15 May 2023.
5. Leishmania: an urgent need for new treatments
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献